Register for OBR daily

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

MACK $9.21 1.3400 +17.03%
TGTX $11.93 1.7100 +16.73%
ATRA $34.18 4.2100 +14.05%
RXDX $9.35 1.1500 +14.02%
GLYC $5.65 0.6699 +13.45%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

SNSS $0.90 -0.0485 -5.11%
GALT $2.25 -0.0900 -3.85%
CLBS $1.48 -0.0300 -1.99%
RDHL $12.55 -0.2300 -1.80%
VBLT $7.71 -0.1200 -1.53%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | Next > | Last >>

2015 Symposium Highlights Notable Advances in Breast Cancer Research

(ASCO) Sept 21, 2015 - Summaries of two notable studies to be presented at the 2015 Breast Cancer Symposium are now available. This will be the final year for the Breast Cancer Symposium, held annually since 2007.
read press release 

ECC 2015 Preview: Scientific Co-chair Peter Naredi, MD, PhD

(Medscape Medical News) Sept 21, 2015 - ECC 2015 Scientific Co-chair Dr Peter Naredi highlights the major themes of the 2015 European Cancer Congress, including the care of elderly cancer patients and the value of patient advocates.
read article (free registration required) 

Cancer Treatment Centers of America at Western Regional Medical Center Launches Next Phase of Immunotherapy Clinical Trial Aimed at Soft-Tissue Cancers

(CTCA) Sept 17, 2015 - New arm of innovative ‘PembroPlus’ clinical trial targets sarcomas.
read press release 

Takeda to Highlight Ixazomib Clinical Development Program at Upcoming International Myeloma Workshop

(StreetInsider) Sept 22, 2015 - Takeda Pharmaceutical Company Limited today announced that it will highlight the ixazomib clinical development program during multiple poster sessions at the upcoming 15th International Myeloma Workshop (IMW 2015) to be held in Rome, Italy, from September 23 to 26, 2015.
read article 

Drug Combination Fights Pancreatic Cancer

(Stanford Medicine) Sept 21, 2015 - A combination of two drugs, one already approved by the Food and Drug Administration, appears to be effective at shrinking pancreatic cancers in laboratory mice, according to a new study by researchers at the Stanford University School of Medicine.
read article 

Relaxed Guidelines on PSA Testing Might Miss Aggressive Tumors: Study

(U.S. News & World Report/HealthDay News) Sept 22, 2015 - Relaxed guidelines on prostate cancer screening may delay diagnosis and treatment of aggressive tumors, a new study suggests.
read article 

Scientists Identify DNA Alterations as Among Earliest to Occur in Lung Cancer Development

(Johns Hopkins) Sept 21, 2015 - Working with tissue, blood and DNA from six people with precancerous and cancerous lung lesions, a team of Johns Hopkins scientists has identified what it believes are among the very earliest “premalignant” genetic changes that mark the potential onset of the most common and deadliest form of disease.
read press release 

Arsenic Trioxide Feasible In Low-, High-Risk Acute Promyelocytic Leukaemia

(medwireNews) Sept 21, 2015 - The use of arsenic trioxide instead of idarubicin in combination with all-trans retinoic acid (ATRA) is a feasible option in patients with acute promyelocytic leukaemia, regardless of risk level, suggests a phase III trial.
read article 

Regorafenib Deemed Not Cost-Effective for Metastatic CRC

(Physician’s Briefing/HealthDay News) Sept 21, 2015 - Given its high cost, regorafenib provides little added benefit as a third-line treatment for metastatic colorectal cancer, according to a study published online Aug. 24 in the Journal of Clinical Oncology.
read article 

Men and Women Face Cancer Differently

(Wall Street Journal) Sept 21, 2015 - Women and men with certain types of cancer appear to take very different approaches in deciding how to treat their disease, a new social-media study from Memorial Sloan Kettering found.
read article (paid subscription required) 

Exclusive: Americans Overpaying Hugely For Cancer Drugs - Academic Study

(Reuters) Sept 22, 2015 - Americans are paying way over the odds for some modern cancer drugs, with pharmaceutical companies charging up to 600 times what the medicines cost to make, according to an independent academic study. The United States also pays more than double the price charged in Europe for these drugs.
read article 

Study: Brentuximab Vedotin Effective, Safe in Elderly Hodgkin Lymphoma Patients Who Cannot Tolerate Standard Chemotherapy

(ASH) Sept 21, 2015 - A study published online in Blood, the Journal of the American Society of Hematology (ASH), reports that bretuximab vedotin is an effective and safe first course of treatment for older Hodgkin lymphoma patients unfit for chemotherapy.
read press release 

Jury Still Out On E-Cigarettes As Cessation Aid, U.S. Doctors Say

(Reuters Health) Sept 21, 2015 - There isn’t enough evidence yet to say whether e-cigarettes are safe or effective for helping people quit smoking, new U.S. guidelines on tobacco cessation conclude.
read article 

The Utility of Cost Discussions Between Patients With Cancer and Oncologists

( Sept 15, 2015 - Many patients with cancer desire cost discussions with doctors, but those discussions are rare. Nevertheless, cost discussions may lower patient costs—usually without altering treatment.
read article 

Genmab's Arzerra Gets Six-Month Review For Maintenance CLL

(PharmaTimes [UK]) Sept 21, 2015 - Genmab is a giant leap closer to getting its cancer drug Arzerra on the market for maintenance treatment of chronic lymphocytic leukaemia, after US regulators said they would review the application in a speedy six-month timeframe.
read article 

US Priority Review For Amgen's Multiple Myeloma Drug

(PharmaTimes [UK]) Sept 21, 2015 - US regulators will undertake a speedy assessment of Amgen’s request to expand the scope of its cancer jab Kyprolis in patients with relapsed multiple myeloma.
read article 

Atossa Genetics Announces FDA Acceptance of Its Investigational New Drug Application to Begin a Phase II Clinical Trial of Fulvestrant for the Treatment of DCIS

(MarketWatch) Sept 21, 2015 - Atossa Genetics Inc. today announced that the U.S. Food and Drug Administration has accepted the Company's Investigational New Drug (IND) application for a clinical trial of Fulvestrant in patients with Ductal Carcinoma in Situ (DCIS) or breast cancer.
read article 

GSK Takes On Gilead With New Two-Drug HIV Treatments

(Yahoo! News/Reuters) Sept 21, 2015 - GlaxoSmithKline is banking on new long-acting HIV medicines and simple two-drug regimens to close the gap on arch-rival Gilead Sciences.
read article 

Merck Antibody Reduces Risk Of Clostridium Difficile Recurrence, Study Says

( Sept 21, 2015 - An experimental antibody developed by Merck & Co Inc was shown in pivotal studies to reduce by about 10 percentage points the risk that infection with Clostridium difficile bacterium, which can cause a deadly diarrhea, will recur.
read article 

Medical Societies to CMS: Not Ready for Stage 3 Meaningful Use

(MedPage Today) Sept 18, 2015 - Dozens of medical societies pressed the Centers for Medicare and Medicaid Services (CMS) to temporarily halt implementation of the final stage of Meaningful Use, a program that rewards and penalizes clinicians based on how effectively they use electronic medical records.
read article (free registration required) 

Clinton Says She'll Roll Out A New Plan This Week To Deal With Costs Of Prescription Drugs

(U.S. News & World Report/Associated Press) Sept 20, 2015 - Hillary Rodham Clinton says she'll soon roll out a proposal for controlling the cost of prescription drugs, a key fix to President Barack Obama's signature health care law.
read article 

F.D.A. Nominee Califf’s Ties to Drug Makers Worry Some

(New York Times) Sept 19, 2015 - Dr. Robert Califf, a cardiologist and renowned clinical researcher, has deeper ties to the pharmaceutical industry than any F.D.A. commissioner in recent memory.
read article 

With $75M, Deciphera Fuels Push For Cancer Drugs—And a Future IPO

(Xconomy Boston) Sept 21, 2015 - Deciphera, of Waltham, MA, this morning raised its biggest round to date—a $75 million haul that’ll fund the company’s plan to develop a particular type of kinase-inhibiting cancer drug.
read article 

Kids With Cancer And Their Parents Ejected From Park Near White House

(Washington Post) Sept 21, 2015 - The U.S. Secret Service ordered hundreds of parents and their cancer-stricken children out of Lafayette Square on Saturday night, barricading the park for at least two hours and disrupting the group’s plans for a candlelight vigil to raise awareness of and research funding for childhood cancer, participants said.
read article (free registration required) 

Fighting Childhood Cancer Takes Center Stage on Capitol Hill

(ASCO in Action) Sept 18, 2015 - On Sept. 18, 2015, the Sixth Annual Childhood Cancer Summit sponsored by the Childhood Cancer Congressional Caucus took place in Washington, D.C.
read article